Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | ADRB2 | P07550 | 8/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 8/20 | 0.45 |
| ▸ | ADRB3 | P13945 | 8/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18100054 | 0.87 | ADRB2 (0.58) | ADRB2ADRB1ADRB3ALDH1A1LMNA | |
| SCHEMBL12134400 | 0.81 | ALDH1A1 (0.47) | L3MBTL1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL2384167 | 0.79 | CYP3A4 (0.52) | L3MBTL1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL22361801 | 0.79 | ALDH1A1 (0.59) | L3MBTL1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL12134405 | 0.78 | MEN1 (0.56) | L3MBTL1ALDH1A1TSHRCYP3A4CYP1A2 | |
| SCHEMBL12576365 | 0.78 | ALDH1A1 (0.47) | L3MBTL1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL12134348 | 0.77 | ALDH1A1 (0.60) | L3MBTL1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL23818692 | 0.74 | ADRB2 (0.41) | L3MBTL1ADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL21567537 | 0.74 | ALDH1A1 (0.77) | L3MBTL1ALDH1A1TSHRCYP3A4CYP1A2 | |
| SCHEMBL21903972 | 0.74 | ABCB1 (0.46) | L3MBTL1ADRB2ADRB1ADRB3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288580-B2 | Benzophenone compound | Double Bond Chemical Ind. Co., Ltd. (TW) | 2012-10-16 | — | — | US | disclosed |
| US-8288580-B2 | Benzophenone compound | Double Bond Chemical Ind. Co., Ltd. (TW) | 2012-10-16 | — | — | US | disclosed |
| US-20110282091-A1 | BENZOPHENONE COMPOUND | Double Bond Chemical Ind. Co., Ltd. (TW) | 2011-11-17 | — | — | US | disclosed |
| US-20110282091-A1 | BENZOPHENONE COMPOUND | Double Bond Chemical Ind. Co., Ltd. (TW) | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282091-A1 | BENZOPHENONE COMPOUND | NPM1, NR0B1, NR4A1 | L3MBTL1 1954/4885ADRB2 856/4885ADRB1 554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.